Deutsche Bank’s Lucid Diagnostics LUCD Stock Holding History

Deutsche Bank’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158K	Buy	148,061 +67,706	+84%	+$73K	﹤0.01%	3351
2026 Q1	$92.4K	Hold	80,355	–	–	﹤0.01%	3307
2025 Q4	$87.6K	Buy	+80,355	New	+$89.8K	﹤0.01%	3333
2025 Q3	–	Sell	-76,301	Closed	-$87.7K	–	3679
2025 Q2	$87.7K	Buy	+76,301	New	+$98.5K	﹤0.01%	3304
2022 Q2	–	Sell	-2,747	Closed	-$9K	–	4240
2022 Q1	$9K	Sell	2,747 -320	-10%	-$1.17K	﹤0.01%	4125
2021 Q4	$16K	Buy	+3,067	New	+$24.9K	﹤0.01%	4137

Other funds holding LUCD

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Deutsche Bank's LUCD Position: Q2 2026 in Review

Deutsche Bank increased its Lucid Diagnostics (LUCD) stake by 84% in Q2 2026, buying an estimated $73K and bringing the position to 148,061 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

Deutsche Bank first reported a position in LUCD in Q4 2021 and has held it in 6 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

Deutsche Bank held 148,061 shares of Lucid Diagnostics worth $158K as of Q2 2026.
Deutsche Bank bought 67,706 Lucid Diagnostics shares in Q2 2026, an estimated $73K.
Lucid Diagnostics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3351 holding.
Deutsche Bank first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 6 quarters since.
116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.